Streetbeat News

Earnings

ITW

Illinois Tool Works (ITW) reported mixed Q3 2024 results with a slight revenue decline but exceeded EPS expectations. The company raised its GAAP EPS forecast for 2024 and plans significant share repurchases.

Portfolio Pulse from Akanksha Bakshi

October 30, 2024 | 2:36 pm

GPN

Global Payments Inc (NYSE:GPN) reported Q3 revenue and EPS below estimates, with revenue at $2.357 billion and EPS at $3.08. Despite this, revenue grew 5% YoY and EPS increased 12%. The company announced a dividend and the sale of its AdvancedMD business to Francisco Partners. GPN shares rose 1.89% following the news.

Portfolio Pulse from Adam Eckert

October 30, 2024 | 2:30 pm

GK

PKB

TT

Trane Technologies reported strong Q3 results, with revenue and EPS surpassing expectations. The company raised its FY24 guidance, indicating positive future growth. Investors can access the stock through ETFs like Invesco Building & Construction ETF and AdvisorShares Gerber Kawasaki ETF.

Portfolio Pulse from Lekha Gupta

October 30, 2024 | 2:30 pm

DAY

Dayforce shares rose after the company reported strong Q3 results and increased its FY24 revenue guidance.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 2:29 pm

TCS

The Container Store's shares are declining following the release of disappointing Q2 adjusted EPS results.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 2:27 pm

HMST

HomeStreet shares declined following the release of disappointing Q3 EPS results.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 2:26 pm

BIIB

Biogen Inc (NASDAQ:BIIB) reported Q3 earnings that beat expectations despite a decline in multiple sclerosis revenues. The company raised its 2024 profit outlook, expecting new product revenues to offset declines in older products. BIIB stock is down 1.37% following the announcement.

Portfolio Pulse from Vandana Singh

October 30, 2024 | 2:21 pm

ABBV

AbbVie Inc. (NYSE:ABBV) reported strong Q3 results, with adjusted EPS of $3.00 and net revenues of $14.46 billion, both beating expectations. Key growth drivers were Skyrizi and Rinvoq, with sales up 50.8% and 45.3% respectively. AbbVie also increased its dividend and announced the acquisition of Aliada Therapeutics. The company raised its 2024 EPS guidance, reflecting confidence in future growth.

Portfolio Pulse from Vandana Singh

October 30, 2024 | 2:17 pm

SMMT

Summit Therapeutics shares are trading lower following the release of their Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 30, 2024 | 2:16 pm

MLM

PKB

SUPP

Martin Marietta Materials Inc (NYSE:MLM) reported a 5% decline in Q3 revenue due to severe weather impacts, missing consensus estimates. The company revised its 2024 guidance downward but expects long-term growth from infrastructure investments. Investors can gain exposure through ETFs like TCW Transform Supply Chain ETF (NYSE:SUPP) and Invesco Building & Construction ETF (NYSE:PKB).

Portfolio Pulse from Lekha Gupta

October 30, 2024 | 2:13 pm